Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03368079
Other study ID # 836211
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 30, 2016
Est. completion date December 30, 2024

Study information

Verified date May 2023
Source University of California, Davis
Contact Randev Sandhu, BS
Phone 916-734-2863
Email rssandhu@ucdavis.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.


Description:

During a properly coordinated swallow, the oropharynx, larynx, and hypopharynx undergo a series of movements that serve to prepare and expand the pharyngoesophageal segment (PES), which is the inlet into the esophagus. Under normal circumstances, a food bolus is safely propelled from the oropharynx, through the PES, and into the esophagus. Surgical and radiation therapy in the head and neck, as well as deficiencies such as poor coordination, mistiming, or obstructing lesions may prevent the food bolus from safely entering the esophagus and instead diverting toward the trachea. A number of patients with severe oropharyngeal dysphagia are not able to tolerate any diet without risking aspiration and subsequent pneumonia, often to a degree severe enough that they cannot manage to safely swallow their secreted saliva. These patients depend on a gastrostomy feeding tube in order to obtain adequate daily nutritional requirements and must suction or spit out their saliva to prevent aspiration and a sensation of asphyxiation. Despite these precautions, many of these patients ultimately suffer life-threatening pneumonia. Investigators will be testing if the use of use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with severe oropharyngeal dysphagia


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date December 30, 2024
Est. primary completion date December 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with videofluoroscopic evidence of aspiration with Rosenbek Penetration Aspiration Scale (PAS) greater than 5 for all tested food consistencies - Gastrostomy tube dependence - Exhaustion of conventional treatment options (physical, medical, and surgical therapies) Exclusion Criteria: - Complete PES stricture - Inability to follow commands - Current malignant disease - No gastrostomy tube present - Less than two years of cancer-free survival (if applicable) - Vulnerable populations: adults unable to consent, pregnant women, and prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Negative Pressure Suction Catheter
The negative pressure suction device to be used in the study will be a Foley catheter. The catheter will be placed through the gastrostomy tube site, directed retrograde through the esophagus, and terminating in the PES.

Locations

Country Name City State
United States UC Davis Medical Center Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Degree of aspiration Degree of aspiration or laryngeal penetration, evaluated by the validated Rosenbek Penetration-Aspiration Scale (PAS). The PAS scale is an 8-point (1 to 8), equal-appearing interval scale:
Material does not enter airway
Material enters the airway, remains above the vocal folds, and is ejected from the airway.
Material enters the airway, remains above the vocal folds, and is not ejected from the airway.
Material enters the airway, contacts the vocal folds, and is ejected from the airway.
Material enters the airway, contacts the vocal folds, and is not ejected from the airway.
Material enters the ariway, passes below the vocal folds, and is ejected into the larynx or out of the airway.
Material enters the airway, passes below the vocal folds, and is not ejected from the trachea despite effort.
Material enters the airway, passes below the vocal folds, and no effort is made to eject.
During VFSE, from the beginning of administration of the first bolus size to completion of the VFSE
Primary Pharyngo-esophageal Segment (PES) opening size Pharyngo-esophageal Segment (PES) is a 2.5 to 4.5 cm manometric high-pressure zone located between the pharynx and esophagus. Normal Pharyngoesophageal segment opening size on lateral view: 0.80 cm +/- 0.40 cm During VFSE, PES is measured when the patient administers 20 cc of liquid barium and the PES is maximally distended.
Secondary Pharyngeal Constriction Ratio (PCR) Pharyngeal Constriction Ratio: is a measure of pharyngeal clearance pressure. It is calculated by dividing the lateral pharyngeal area during maximal contraction by the area with a 1 cc bolus held in the oral cavity. The area is determined by onscreen tool provided. Normal PCR: 0.14 +/- 0.28 Measurement of the pharyngeal area during maximum contraction are taken after administration of 20 cc liquid barium. The pharyngeal area at rest is measured when 1 cc bolus is held in the oral cavity.
Secondary Oropharyngeal transit time Oropharyngeal transit time is measured when the patient administers 20 cc of liquid barium. Normal oropharyngeal transit time: 0.42 sec +/- 0.36 sec Time from when bolus head first passes posterior nasal spine to time bolus head enters base of vallecula
Secondary Hypopharyngeal transit time Hypopharyngeal transit time: is measured when the patient administers 20 cc of liquid barium. Normal Hypopharyngeal transit time: 0.77 sec +/- 0.26 sec Time from when bolus head exits the vallecula to time when bolus tale exits PES
See also
  Status Clinical Trial Phase
Completed NCT03284892 - Screening and Intervention of Postextubation Dysphagia N/A
Not yet recruiting NCT05958173 - Effects of 6-month of Treatment With TRPV1 and TRPA1 Agonists in Older Patients With OD N/A
Recruiting NCT04359199 - QUantitative Assessment of Swallowing After Radiation (QUASAR)
Terminated NCT03387267 - Videofluoroscopic Swallowing Study (VFSS) N/A
Recruiting NCT06250426 - Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia N/A
Not yet recruiting NCT02874352 - Incidence of Dysphagia in Intensive Care Patients With Tracheostomy N/A
Recruiting NCT05720871 - Treatment of Chronic Post-stroke Oropharyngeal Dysphagia With Paired Stimulation N/A
Recruiting NCT04130867 - Rehabilitation Manometry Study
Completed NCT05405829 - Health Education to Caregivers to Reduce Aspiration Pneumonia N/A
Recruiting NCT05421689 - Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia Phase 1/Phase 2
Recruiting NCT02838316 - Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia Phase 1
Enrolling by invitation NCT05325658 - Influence of Modified Diet, Exercise and Electrical Swallowing Muscle Stimulation on Swallowing Function and Quality of Life in Elderly Patients With Oropharyngeal Dysphagia
Completed NCT02959450 - Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia N/A
Recruiting NCT05278039 - Training Swallowing Initiation During Expiration N/A
Completed NCT02396992 - Minimal-Massive Intervention in Elderly Patients With Dysphagia N/A
Not yet recruiting NCT05862142 - A Predictive Model for Oropharyngeal Dysphagia in Non-hospitalized Older Patients
Recruiting NCT04581486 - Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia N/A
Recruiting NCT06368830 - Oral and Swallowing Function in Older Adults
Completed NCT03328702 - CPAP to Improve Swallow Function Post Total Laryngectomy N/A
Terminated NCT01971320 - Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia Phase 3